Neumología

Resultados: 679
Tipo Título / Nombre Autor(es) Año
Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2 Cinesi Gómez C, Peñuelas Rodríguez Ó, Luján Torné M, Egea Santaolalla C, Masa Jiménez JF, García Fernández J, et al 2020
Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea Masa JF, Mokhlesi B, Benítez I..., Gómez de Terreros Caro FJ, Corral-Peñafiel J, Spanish Sleep Network, et al 2020
The Effect of Hospital Discharge with Empiric Noninvasive Ventilation on Mortality in Hospitalized Patients with Obesity Hypoventilation Syndrome: An Individual Patient Data Meta-Analysis Mokhlesi B, Masa JF, Afshar M, Almadana Pacheco V, Berlowitz DJ, Borel JC, et al 2020
Weight Loss Interventions as Treatment of Obesity Hypoventilation Syndrome: A Systematic Review Tamae Kakazu M, Soghier I, Afshar M, Brozek JL, Wilson KC, Masa JF, et al 2020
Echocardiographic Changes with Positive Airway Pressure Therapy in Obesity Hypoventilation Syndrome: Long-term Pickwick Randomized Controlled Trial Masa JF, Mokhlesi B, Benítez I, Mogollón MV, Gómez de Terreros FJ, Corral J, et al 2020
Clinical Practice Guideline Summary for Clinicians: Evaluation and Management of Obesity Hypoventilation Syndrome Gómez de Terreros FJ, Cooksey JA, Sunwoo BY, Mokhlesi B, Masa JF, Ruminjo JK, et al 2020
Intra- and Inter-Physician Agreement in Therapeutic Decision for Sleep Apnea Syndrome Lugo VM, Torres M, Garmendia O, Suárez-Giron M, Ruiz C..., Masa JF, et al 2020
Estudio multicéntrico, aleatorizado, doble ciego, con grupos paralelos y controlado con placebo de mepolizumab 100 mg SC como tratamiento complementario en participantes con EPOC, que experimentan exacerbaciones frecuentes y caracterizada por los niveles de eosinófilos (estudio 208657) Servicio de Neumología 2019
Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study") Trigueros JA, Riesco JA, Alcázar-Navarrete B, Campuzano A, Pérez J 2019
The impact trial: is single-inhaler triple pherapy (FF/UMEC/VI) cost -effective versus dual therapy with inhaled corticosteroid plus long-acting beta agonist (FF/VI) in patients with copd in Spain? Paly V, Vallejo Aparicio LA, Schroeder M, Martin A, Izquierdo Alonso JL, Riesco Miranda JA, et al 2019